NCT06281496View on ClinicalTrials.gov

AlloCare - Support and Management of Late Effects After Allogeneic Hematopoietic Stem Cell Transplantation

NARecruitingINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

November 1, 2024

Primary Completion Date

October 1, 2027

Study Completion Date

December 1, 2027

Conditions

Hematological Diseases

Interventions

BEHAVIORAL

AlloCare

Survivorship supportive care

Trial Locations (1)

2100

RECRUITING

Rigshospitalet, Copenhagen

All Listed Sponsors

collaborator

Danish Cancer Society

OTHER

lead

Rigshospitalet, Denmark

OTHER